Marine bacteria: Potential sources for compounds to overcome antibiotic resistance

Applied Microbiology and Biotechnology

Volumn 97, Issue 11, 2013, Pages 4763-4773

  Eom, Sung Hwan ^a   Kim, Young Mog ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Anti MRSA substance; Antibiotic resistance; Marine bacteria; Methicillin resistant Staphylococcus aureus

Indexed keywords

ALTERNATIVE THERAPY; ANTI-MRSA SUBSTANCE; ANTIBACTERIAL EFFECTS; ANTIBIOTIC RESISTANCE; GRAM-POSITIVE BACTERIUM; MARINE BACTERIUM; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; THERAPEUTIC TREATMENTS;

ANTIBIOTICS; DRUG THERAPY; PEPTIDES;

BACTERIA;

2,4 DIACETYLPHLOROGLUCINOL; ABYSSOMICIN C; ACTINOMYCETES V; ANTIINFECTIVE AGENT; BOGOROL A; ETAMYCIN A; FIJIMYCINS A; FIJIMYCINS C; FTSZ PROTEIN; FURANONE DERIVATIVE; LIPOXAZOLIDINONE A; LOLOATINS A; LOLOATINS B; LOLOATINS C; LOLOATINS D; LYDICAMYCIN; MOIRAMIDE B; PESTALONE; PSEUDOMONIC ACID; PYRONE DERIVATIVE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; YPU 0037 A;

ANTIBIOTIC RESISTANCE; DISEASE TREATMENT; INFECTIOUS DISEASE; MARINE ECOSYSTEM; MICROBIAL COMMUNITY; PEPTIDE; PUBLIC HEALTH; SEAWATER;

ACTINOBACTERIA; ALTEROMONAS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACILLUS; BACTERIOPHAGE; CONCENTRATION RESPONSE; CYTOKINESIS; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; GENE SEQUENCE; IMMUNOGENICITY; MARINE BACTERIUM; MARINE ENVIRONMENT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRESSURE; PSEUDOALTEROMONAS; PSEUDOMONAS; REVIEW; SALINITY; STREPTOMYCES; WATER TEMPERATURE;

ANTI-BACTERIAL AGENTS; AQUATIC ORGANISMS; BACTERIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84878016666     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-4905-y     Document Type: Review

References (80)

1. Allen JRF, Holmstedt BR (1980) The simple β-carboline alkaloids. Phytochemistry 19:1573-1582
2. Apfel CM, Locher H, Evers S, Takacs B, Hubschwerlen C, Pirson W, Page MGP, Keck W (2001) Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother 45:1058-1064
3. Arcus VL, Lott JS, Johnston JM, Baker EN (2006) The potential impact of structural genomics on tuberculosis drug discovery. Drug Discov Today 11:28-34
4. Barsby T, Kelly MT, Gagne SM, Andersen RJ (2001) Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics. Org Lett 3:437-440
5. Bartlett PA, Johnson CR (1985) An inhibitor of chorismate mutase resembling the transition state conformation. J Am Chem Soc 107:7792-7793
6. Black MT, Hodgson J (2005) Novel target sites in bacteria for overcoming antibiotic resistance. Adv Drug Deliv Rev 57:1528-1538
7. Borysowski J, Weber-Dabrowska B, Gorski A (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med 231:366-377
8. Boyle-Vavra S, Berke SK, Lee JC, Daum RS (2000) Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 44:272-277
9. Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178-182
10. Clements JM, Ayscough A, Keavey K, East SP (2002) Peptide deformylase inhibitors, potential for a new class of broad spectrum antibacterials. Curr Med Chem 1:239-249
11. Cueto M, Jensen PR, Kauffman C, Fenical W, Lobkovsky E, Clardy J (2001) Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J Nat Prod 64:1444-1446
12. Dabrowska K, Switala-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A (2005) Bacteriophage penetration in vertebrates. J Appl Microbiol 98:7-13
13. Ding L, Maier A, Fiebig HH, Lin WH, Peschel G, Hertweck C (2012) Kandenols A-E, eudesmenes from an endophytic Streptomyces sp. of the mangrove tree Kandelia candel. J Nat Prod 75:2223-2227
14. Eom SH, Park JH, Yu DU, Choi JI, Choi JD, Lee MS, Kim YM (2011) Antimicrobial activity of brown alga Eisenia bicyclis against methicillin-resistant Staphylococcus aureus. Fish Aquat Sci 14:251-256
15. Fenical W (1993) Chemical studies of marine bacteria: developing a new resource. Chem Rev 93:1673-1683
16. Finland M (1979) Emergence of antibiotic resistance in hospital 1935-1975. Rev Infect Dis 1:4-21
17. Fischetti VA, Nelson D, Schuch R (2006) Reinventing phage therapy: are the parts greater than the sum? Nat Biotechnol 24:1508-1511
18. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D, Claverie JM (2006) Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2:e7
19. Freiberg C, Brotz-Oesterhelt H (2005) Functional genomics in antibacterial drug discovery. Drug Discov Today 10:927-935
20. Fu P, Liu P, Qu H, Wang Y, Chen D, Wang H, Li J, Zhu W (2011) α-Pyrones and diketopiperazine derivatives from the marine-derived actinomycete Nocardiopsis dassonvillei HR10-5. J Nat Prod 74:2219-2223
21. Furumai T, Eto K, Sasaki T, Higuchi H, Onaka H, Saito N, Fujita T, Naoki H, Igarashi Y (2002) TPU-0037-A, B, C and D, novel lydicamycin congeners with anti-MRSA activity from Streptomyces platensis TP-A0598. J Antibiot 55:873-880
22. Gerard JM, Haden P, Kelly MT, Andersen RJ (1999) Loloatins A-D, cyclic decapeptide antibiotics produced in culture by a tropical marine bacterium. J Nat Prod 62:80-85
23. Guignard B, Entenza JM, Moreillon P (2005) Beta-lactams against methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 5:479-489
24. Haese A, Keller U (1988) Genetics of actinomycin C production in Streptomyces chrysomallus. J Bacteriol 170:1360-1368
25. Hancock REW (2007) The end of an era? Nat Rev Drug Discov 6:28
26. Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y, Nakae T, Sunakawa K (2007) Characterization of oxacillin-susceptible mecA positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother 13:79-86
27. Hughes CC, Prieto-Davo A, Jensen PR, Fenical W (2008) The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org Lett 10:629-631
28. Isnansetyo A, Horikawa M, Kamei Y (2001) In vitro anti-methicillin resistant Staphylococcus aureus activity of 2,4-diacetylphloroglucinol produced by a Pseudomonas sp AMSN isolated from a marine alga. J Antimicrob Chemother 47:724-725
29. T, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:480-488
30. T. Int J Antimicrob Agents 34:131-135
31. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K (2001) Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45:1323-1336
32. Jevons MP (1961) Celbenin-resistant staphylococci. Br Med J 1:124-125
33. Kanoh K, Adachi K, Matsuda S, Shizuri Y, Yasumoto K, Kusumi T, Okumura K, Kirikae T (2008) New sulfoalkylresorcinol from marine-derived fungus, Zygosporium sp. KNC52. J Antibiot 61:192-194
34. Katayama Y, Robinson DA, Enright MC, Chambers HF (2005) Genetic background affects stability of mecA in Staphylococcus aureus. J Clin Microbiol 43:2380-2383
35. Kaur K, Jain M, Kaur T, Jain R (2009) Antimalarials from nature. Bioorg Med Chem 17:3229-3256
36. Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and Deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13:1840-1846
37. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771
38. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505-520
39. Lee DS (2009) Isolation and characterization of anti-MRSA (methicillin-resistant Staphylococcus aureus) substances from marine organisms. Ph.D. dissertation, Department of Microbiology, Pukyong National University, Busan. Chapter 1, pp. 2-23.
40. Lee DS, Kang MS, Hwang HJ, Eom SH, Yang JY, Lee MS, Lee WJ, Jeon YJ, Choi JS, Kim YM (2008) Synergistic effect between dieckol from Ecklonia stolonifera and β-lactams against methicillin-resistant Staphylococcus aureus. Biotechnol Bioprocess Eng 13:758-764
41. Levy SB (1998) Multidrug resistance - a sign of the times. N Engl J Med 338:1367-1368
42. Levy SB (2005) Antibiotic resistance - the problem intensifies. Adv Drug Deliv Rev 57:1446-1450
43. Li S, Tian X, Niu S, Zhang W, Chen Y, Zhang H, Yang X, Zang W, Li W, Zamg S, Ju J, Zhang C (2011) Pseudonocardians A-C, new diazaanthraquinone derivatives from a deep-sea actinomycete Pseudonocardia sp. SCSIO 01299. Mar Drugs 9:1428-1439
44. Lim Y, Chang JH, Kim JH, Shu JW, Jung JK, Lee CH (1995) Structure elucidation of a potent anti-MRSA antibiotic AM3, produced by Streptomyces sp. Agric Chem Biotechnol 38:516-521
45. Lloyd AW (1998) Monitor: molecules and profiles. Drug Discov Today 3:480-482
46. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520-532
47. Mansoor TA, Ramalhete C, Molnar J, Mulhovo S, Ferreira MJU (2009) Tabernines A-C, β-carbolines from the leaves of Tabernaemontana elegans. J Nat Prod 72:1147-1150
48. Margolis PS, Hackbarth CJ, Young DC, Wang W, Chen D, Yuan Z, White R, Trias J (2000) Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob Agents Chemother 44:1825-1831
49. Matsuda T, Freeman TA, Hilbert DW, Duff M, Fuortes M, Stapleton PP, Daly JM (2005) Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137:639-646
50. McArthur KA, Mitchell SS, Tsueng G, Rheingold A, White DJ, Grodberg J, Lam KS, Potts BCM (2008) Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J Nat Prod 71:1732-1737
51. Michelle S, Teisan S, Tsueng G, Venkat M, Kin L (2008) Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920. J Ind Microb Biotech 35:761-765
52. Mills SD (2006) When will the genomics investment pay off for antibacterial discovery? Biochem Pharmacol 71:1096-1102
53. Monaghan RL, Barrett JF (2006) Antibacterial drug discovery - then, now and the genomics future. Biochem Pharmacol 71:901-909
54. Mondol MM, Tareq FS, Kim JH, Lee MA, Lee HS, Lee YJ, Lee JS, Shin HJ (2011) Cyclic ether-containing macrolactins, antimicrobial 24-membered isomeric macrolactones from a marine Bacillus sp. J Nat Prod 74(12):2582-2587
55. Nascimento GGF, Locatelli J, Freitas PC, Silva GL (2000) Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz J Microbiol 31:247-256
56. Needham J, Kelly MT, Ishige M, Andersen RJ (1994) Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesis. J Org Chem 59:2058-2063
57. Park JY, Jin JS, Kang HY, Jeong EH, Lee JC, Lee YC, Seol SY, Cho DT, Kim J (2007) A comparison of adult and pediatric methicillin-resistant Staphylococcus aureus isolates collected from patients at a university hospital in Korea. J Microbiol 45:447-452
58. Proksa B, Uhrin D, Sturdikova M, Fuska J (1990) 1-Acetyl-β- carboline, a new metabolite of Streptomyces kasugaensis. Scta Biotechnol 10:337-340
59. Riedlinger J, Reicke A, Zähner H, Krismer B, Bull AT, Maldonado LA, Ward AC, Goodfellow M, Bister B, Bischoff D, Süssmuth RD, Fiedler HP (2004) Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J Antibiot 57:271-279
60. Sakharkar KR, Sakharkar MK, Chow VT (2004) A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol 4:355-360
61. Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91:72S-75S
62. Shin HJ, Lee HS, Lee DS (2010) The synergistic antibacterial activity of 1-acetyl-β-carboline and β-lactams against methicillin-resistant Staphylococcus aureus (MRSA). J Microbiol Biotechnol 20:501-505
63. Shiota S, Shimizu M, Sugiyama J, Morita Y, Mizushima T, Tsuchiya T (2004) Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of β-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 48:67-73
64. Shiozawa H, Kagasaki T, Kinoshita T, Haruyama H, Domon H, Utsui Y, Kodama K, Takahashi S (1993) Thiomarinol, a hybrid antimicrobial antibiotic produced by a marine bacterium fermentation, isolation, structure and antimicrobial activity. J Antibiot 46:1834-1842
65. Shiozawa H, Kagasaki T, Torikata A, Tanaka N, Fujimoto K, Hata T, Furukawa Y, Takahashi S (1995) Thiomarinol B, thiomarinol C, new antimicrobial antibiotics produced by a marine bacterium. J Antibiot 48:907-909
66. Shiozawa H, Shimada A, Takahashi S (1997) Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium; isolation, structure, and antimicrobial activity. J Antibiot 50:449-452
67. Singh MP, Kong F, Janso JE, Arias DA, Suarez PA, Bernan VS, Petersen PJ, Weiss WJ, Carter G, Greenstein M (2003) Novel alpha-pyrones produced by a marine Pseudomonas sp. F92S91: taxonomy and biological activities. J Antibiot 56:1033-1044
68. Soria-Mercado IE, Prieto-Davo A, Jensen PR, Fenical W (2005) Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 68:904-910
69. Sulakvelidze A, Alavidze Z, Morris JG (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649-659
70. Sun P, Maloney KN, Nam SJ, Haste NM, Raju R, Aalbersberg W, Jensen PR, Nizet V, Hensler ME, Fenical W (2011) Fijimycins A-C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp. Bioorg Med Chem 19:6557-6562
71. Swenson JM, Lonsway D, McAllister S, Thompson A, Jevitt L, Zhu W, Patel JB (2007) Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn Microbiol Infect Dis 58:33-39
72. Tan RX, Zou WX (2001) Endophytes: a rich source of functional metabolites. Nat Prod Rep 18:448-459
73. Trujillo JI, Meyers MJ, Anderson DR, Hegde S, Mahoney MW, Vernier WF, Buchler IP, Wu KK, Yang S, Hartmann SJ, Reitz DB (2007) Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett 17:4657-4663
74. Vaudaux P, Francois P, Berger-Bachi B, Lew DP (2001) In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptides-susceptible, methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother 47:163-170
75. Witte W (1999) Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 44:1-9
76. Witte W, Pasemann B, Cuny C (2007) Detection of low-level oxacillin resistance in mecA-positive Staphylococcus aureus. Clin Microbiol Infect 13:408-412
77. Woodford N (2005) Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci. Clin Microbiol Infect 11:2-21
78. Young RN (1999) Importance of biodiversity to the modern pharmaceutical industry. Pure Appl Chem 71:1655-1661
79. Yuan Z, White RJ (2006) The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics. Biochem Pharmacol 71:1042-1047
80. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T (2001) Mechanism of synergy between epigallocatechin gallate and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45:1737-1742